Advertisement

Topics

Arcus Biosciences Company Profile

11:12 EDT 17th October 2017 | BioPortfolio

Arcus Biosciences (“Arcus”) is a biotechnology company focused on the discovery and development of innovative cancer immunotherapies. Arcus was founded in 2015 by Terry Rosen and Juan Jaen, the co-founders of Flexus Biosciences, which in February 2015 was acquired by Bristol-Myers Squibb to access Flexus’s IDO inhibitor, which was in preclinical development at the time and is now referred to as BMS-986205. Arcus has several programs targeting important immuno-oncology pathways, including a first-in-class dual adenosine receptor antagonist and a PD-1 antibody, both of which are about to enter phase 1 studies, as well as a first-in-class small molecule inhibitor of CD73 and a TIGIT antibody, which are in IND-enabling studies. Arcus has over 70 employees with extensive expertise in medicinal chemistry, immunology, biochemistry, pharmacology, and structural biology. To date, Arcus has raised $120mm in funding from investors including GV (previously known as Google Ventures), Foresite Capital, The Column Group, Invus LP, Novartis, Celgene, Taiho Ventures, Stanford University, and DROIA, as well as from senior management. The company is based in Hayward, CA.


News Articles [529 Associated News Articles listed on BioPortfolio]

Taiho options rights to Arcus's immuno-oncology candidates

Arcus Biosciences Inc. granted Taiho Pharmaceutical Co. Ltd. an option to license exclusive rights in Asia (including Japan but excluding China) to develop and commercialize cancer immunotherapies fro...

Harbin Gloria, WuXi Biologics Sign $818 Million Deal for Ex-China Rights to PD-1 Candidate

Harbin Gloria Pharma and WuXi Biologics have entered an ex-China agreement for a PD-1 antibody with Arcus Biosciences of California's Bay Area in a deal worth up to $818 million. The PD-1 candidate, G...

WuXi and Gloria grant Arcus rights to anti-PD-1 antibody; deal worth up to $816mm

Wuxi Biologics and partner Harbin Gloria Pharmaceuticals Co. Ltd. granted Arcus Biosciences Inc. exclusive rights to develop and sell the anti-PD-1 antibody GSL010 in North America, Europe, Japan, and...

Arcus Biosciences Appoints To Its Board Of Directors

  Life Sciences Jobs   ...

Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma

  Life Sciences Jobs   ...

Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+

  Life Sciences Jobs   ...

Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $1 Billion+

  Life Sciences Jobs   ...

Chinese biotechs sign extensive I-O deal with Arcus Biosciences worth up to $816 million

WuXi Biologics, a biopharmaceutical services firm specializing in research and development, and its partner…

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

PubMed Articles [62 Associated PubMed Articles listed on BioPortfolio]

Familial Hypercholesterolemia: Xanthelesma, Arcus Corneae & Tendon Xanthomas.

Draft Genome Sequences of Trichophyton rubrum CMCC(F)T1i and Trichophyton violaceum CMCC(F)T3l by Illumina 2000 and Pacific Biosciences.

One strain of Trichophyton rubrum CMCC(F)T1i (=CBS 139224) isolated from onychomycosis and one strain of Trichophyton violaceum CMCC(F)T3l (=CBS 141829) isolated from tinea capitis in China were whole...

Introduction.

Amnesia and criminal responsibility.

Front cover.

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Comparison Between Transvaginal Mesh and Traditional Surgery for Pelvic Organ Prolapse

Pelvic organ prolapse is characterized by a lack of pelvic floor support causing the pelvic organs and vaginal walls to protrude. For decades, suture repair techniques have been the primar...

Safety Study of Pelvic Organ Prolapse Repair Using Transvaginal Mesh

Pelvic organ prolapse is characterized by a lack of pelvic floor support causing the pelvic organs and vaginal walls to protrude. For decades, suture repair techniques have been the prima...

Companies [343 Associated Companies listed on BioPortfolio]

Arcus Biosciences

Arcus Biosciences (“Arcus”) is a biotechnology company focused on the discovery and development of innovative cancer immunotherapies. Arcus was founded in 2015 by Ter...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

More Information about "Arcus Biosciences" on BioPortfolio

We have published hundreds of Arcus Biosciences news stories on BioPortfolio along with dozens of Arcus Biosciences Clinical Trials and PubMed Articles about Arcus Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Arcus Biosciences Companies in our database. You can also find out about relevant Arcus Biosciences Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record